phenobarbital has been researched along with Morphine Dependence in 21 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Morphine Dependence: Strong dependence, both physiological and emotional, upon morphine.
Excerpt | Relevance | Reference |
---|---|---|
"Thrombocytosis was not related to withdrawal symptoms or treatment (phenobarbital or paregoric)." | 1.26 | Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users. ( Burstein, Y; Giardina, PJ; Kandall, SR; Peterson, CM; Rausen, AR; Siljestrom, K, 1979) |
" Physical dependence on phenobarbital and diazepam was produced using the same dosage schedules as with morphine." | 1.25 | Physical dependence on morphine, phenobarbital and diazepam in rats by drug-admixed food ingestion. ( Suzuki, T; Tagashira, E; Yanaura, S, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ROSENTHAL, T | 1 |
PATRICK, SW | 1 |
KRUG, DC | 1 |
Yoshimura, K | 2 |
Horiuchi, M | 1 |
Inoue, Y | 1 |
Yamamoto, K | 2 |
Eisenberg, RM | 2 |
Yanaura, S | 4 |
Suzuki, T | 3 |
Mito, H | 1 |
Shishido, A | 1 |
Kobayashi, N | 1 |
Burstein, Y | 1 |
Giardina, PJ | 1 |
Rausen, AR | 1 |
Kandall, SR | 1 |
Siljestrom, K | 1 |
Peterson, CM | 1 |
Greer, CA | 1 |
Alpern, HP | 1 |
Collins, AC | 1 |
Tagashire, E | 1 |
Banerjee, U | 2 |
Tagashira, E | 2 |
Wong, CL | 1 |
Roberts, MB | 1 |
Kaneto, H | 1 |
Koida, M | 1 |
Nakanishi, H | 1 |
Sasano, H | 1 |
Puri, SK | 1 |
Lal, H | 1 |
Hasse, HE | 1 |
Schiefgen, W | 1 |
Schönhöfer, P | 1 |
Gray, GR | 1 |
Smith, DE | 1 |
Wesson, DR | 1 |
Sheppard, CW | 1 |
McMullin, GP | 1 |
Mobarak, AN | 1 |
Zelson, C | 1 |
Kahn, EJ | 1 |
Neumann, L | 1 |
Polk, G | 1 |
Maynert, EW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Examination of Palonosetron and Hydroxyzine Pre-treatment as a Possible Method to Reduce the Objective Signs of Experimentally-induced Acute Opioid Withdrawal in Humans: a Double-blind, Randomized, Placebo-controlled Crossover Study[NCT00661674] | 10 participants (Actual) | Interventional | 2008-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"The OOWS is a 13-item instrument documenting physically observable signs of withdrawal, which are rated as present (1) or absent (0) during the observation period. Maximum score possible = 13, minimum score possible = 0. T=15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~OOWS scores at T=180 is the primary outcome measure of the study compared with baseline OOWS scores at T=-30 (30 minutes prior to study medication administration). Reported time frames are in relation to time past since administration of study medications.~Mean post-Naloxone OOWS scores (+/- SEM) were determined for pretreatment groups" (NCT00661674)
Timeframe: Change from baseline in OOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (OOWS Scale) (Mean) |
---|---|
Placebo | 3.5 |
Palonosetron | 1.0 |
Palonosetron + Hydroxyzine | 0 |
"The SOWS score is composed of 16 subjective symptoms rated on a scale of 0 to 4 (0=not at all, 4=extremely) based on what subjects were experiencing at the time of testing. 15 minutes post naloxone administration coordinates with T = 180 (min) for the entire study session.~The highest score possible (64) would indicate that the individual was experiencing every symptom of opioid withdrawal to the fullest extent possible while the lowest score (0) would indicate that the individual was not experiencing any symptoms of opioid withdrawal.~Mean post-naloxone SOWS scores (+/- SEM) were computed for pretreatment groups: Placebo, palonosetron, and palonosetron with hydroxyzine" (NCT00661674)
Timeframe: Change from baseline in SOWS score at 180 minutes (15 minutes post naloxone administration)
Intervention | units on a scale (SOWS Scale) (Mean) |
---|---|
Placebo | 6.0 |
Palonosetron | 4.0 |
Palonosetron + Hydroxyzine | 3.5 |
21 other studies available for phenobarbital and Morphine Dependence
Article | Year |
---|---|
CONGENITAL NEONATAL NARCOTICS ADDICTION: A NATURAL HISTORY.
Topics: Chlorpromazine; Female; Humans; Maternal-Fetal Exchange; Meperidine; Methadone; Morphine Dependence; | 1964 |
[Pharmacological studies on drug dependence. (III): Intravenous self-administration of some CNS-affecting drugs and a new sleep-inducer, 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), in rats].
Topics: Animals; Central Nervous System Agents; Cocaine; Diazepam; Humans; Hypnotics and Sedatives; Injectio | 1984 |
Further studies on the acute dependence produced by morphine in opiate naive rats.
Topics: Amphetamine; Animals; Corticosterone; Diazepam; Drug Tolerance; Humans; Male; Morphine; Morphine Dep | 1982 |
[Neuropharmacological studies on drug dependence (II). Changes in spontaneous motor activity, EEG and brain monoamines during the period of dependence development and of abrupt withdrawal in rats, with special reference to circadian rhythm (author's trans
Topics: Animals; Biogenic Amines; Brain; Circadian Rhythm; Cocaine; Diazepam; Electroencephalography; Humans | 1980 |
[Changes in the osmotic fragility of erythrocyte membrane in morphine- and phenobarbital-dependent rats (author's transl)].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Fasting; Humans; Male; Morphine Dependence; Or | 1979 |
Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users.
Topics: Amphetamine; Cocaine; Diazepam; Female; Heroin Dependence; Humans; Infant; Infant, Newborn; Infant, | 1979 |
Increased CNS sensitivity to flurothyl as a measure of physical dependence in mice following morphine, phenobarbital, and ethanol treatment.
Topics: Animals; Ethanol; Flurothyl; Humans; Male; Mice; Mice, Inbred C57BL; Morphine Dependence; Phenobarbi | 1976 |
[Dependence on and preference for morphine (II). Comparison among morphine, phenobarbital and diazepam].
Topics: Animals; Body Weight; Choice Behavior; Decision Making; Diazepam; Female; Humans; Male; Methods; Mor | 1975 |
Conditioned learning in young rats born of drug-addicted parents and raised on addictive drugs.
Topics: Animals; Animals, Newborn; Avoidance Learning; Birth Weight; Body Weight; Conditioning, Psychologica | 1975 |
Physical dependence on morphine, phenobarbital and diazepam in rats by drug-admixed food ingestion.
Topics: Animals; Body Weight; Diazepam; Diet; Feeding Behavior; Female; Humans; Levallorphan; Male; Morphine | 1975 |
Conditioned avoidance behavior in pretrained rats intermittently treated with addictive drugs.
Topics: Amphetamine; Animals; Avoidance Learning; Body Weight; Conditioning, Operant; Dose-Response Relation | 1975 |
The possible role of brain histamine and H1 and H2 receptors in the development of morphine tolerance and physical dependence in mice.
Topics: Animals; Drug Tolerance; Female; Histidine; Humans; Male; Metiamide; Mice; Mice, Inbred Strains; Mor | 1975 |
Effects of chronic treatment with diazepam, phenobarbital, or amphetamine on naloxone-precipitated morphine withdrawal.
Topics: Amphetamine; Animals; Corticosterone; Diazepam; Male; Mice; Morphine Dependence; Motor Activity; Nal | 1985 |
[Drug dependence in rats: substitution test and sequential changes in body weight].
Topics: Animals; Body Weight; Codeine; Drug Therapy, Combination; Humans; Male; Meprobamate; Morphine; Morph | 1974 |
A scoring system for abstinence syndrome in morphine dependent mice and application to evaluate morphine type dependence liability of drugs.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Humans; Male; Meperidine; Methadone; Mi | 1973 |
Reduced threshold to pain induced aggression specifically related to morphine dependence.
Topics: Aggression; Animals; Dextroamphetamine; Drug Synergism; Electroshock; Ethanol; Humans; Male; Morphin | 1974 |
[Emergencies in drugged adolescents].
Topics: Adolescent; Amitriptyline; Benzazepines; Cannabis; Emergencies; Hallucinogens; Humans; Male; Morphin | 1972 |
Outpatient barbiturate withdrawal using phenobarbital.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Amobarbital; Barbiturates; Community Healt | 1972 |
Congenital narcotic addiction.
Topics: Chlorpromazine; Humans; Infant, Newborn; Male; Morphine Dependence; Phenobarbital; Water-Electrolyte | 1970 |
Heroin withdrawal syndrome.
Topics: Chlorpromazine; Female; Heroin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal E | 1970 |
VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.
Topics: Adrenal Medulla; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Brain Stem; Cats; Dep | 1968 |